From the Food and Drug Administration.
Henney
J E
JE
Commissioner of Food and Drugs, Rockville, MD 20857, USA.
D000280:Administration, Inhalation; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy; D019819:Budesonide / Q000008:administration & dosage*; D002243:Carbolines / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D004348:Drug Labeling; D004567:Electrodes, Implanted; D005260:Female; D006310:Hearing Aids; D006319:Hearing Loss, Sensorineural / Q000628:therapy; D006801:Humans; D007223:Infant; D008297:Male; D009330:Nebulizers and Vaporizers; D012702:Serotonin Antagonists / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D000893:Anti-Inflammatory Agents; D002243:Carbolines; D012702:Serotonin Antagonists; C090840:alosetron; D019819:Budesonide